`
`
`
`
` !"#$ÿ#&ÿ'##()*$+,-#&"#$./01ÿ !23435ÿ#&.#$
`ÿ
`789:;:<ÿ=>?=@ÿ
`AB7CDB7CEÿCF?ÿ=
`ÿEFÿ
`GAH7GIBAJK7ELCMÿAMJ77B7CE
`ÿ5/N'ÿOP QRP Q5ÿQS.ÿ#ÿ5SÿTOU TVPOWX 53QYÿOYW P Q5ÿZ0/N'ÿ[O1,\]1,\0^_ÿN'ÿ1`],ÿ`\]ÿ,\0,a,]ÿN\0bÿ`'ÿbc
`Oded'0ÿ)*fÿ)&#$fÿghÿ`\]ÿ`1b\eÿ 0b\ÿi/`a1`j,d0Nj`k'fÿ3\j.fÿ`ÿR,k`l`a,ÿjbamba`0Nb\ÿZ0/,ÿ[nb1m`\h^_oÿOUÿi/`a1`fÿ3\jfÿ`\ÿSpk`/b1`
`jbamba`0Nb\ÿZ[OU^_oÿTnTÿQ`0Nb\`kfÿUUnfÿ`\ÿSpk`/b1`ÿkN1N0,]ÿkN`gNkN0hÿjb1m`\hZ[TnT^_oÿ`\]ÿRahÿna,,pÿiabq,j0fÿUUnfÿ`\ÿSpk`/b1`
`kN1N0,]ÿkN`gNkN0hÿjb1m`\hZ[Rni^_ÿ`'ÿ`\ÿ`1,\]1,\0ÿ0bÿ0/,ÿTOU TVPOWX 53QYÿOYW P Q5ÿ]`0,]ÿQbr,1g,aÿ#sfÿ)&#s.
`ÿ
`J7tLEAHG
`ÿQSufÿ52 W vSW fÿN\ÿjb\'N],a`0Nb\ÿcbaÿ`\]ÿbcÿ0/,ÿ1d0d`kÿmab1N','fÿjbr,\`\0'ÿ`\]ÿjb\]N0Nb\'ÿ/,a,N\`c0,aÿ',0ÿcba0/ÿ`\]
`b0/,aÿebb]ÿ`\]ÿr`kd`gk,ÿjb\'N],a`0Nb\fÿ0/,ÿa,j,Nm0ÿ`\]ÿ'dccNjN,\jhÿbcÿl/Nj/ÿ`a,ÿ/,a,ghÿ`jp\blk,]e,]fÿ0/,ÿm`a0N,'ÿ/,a,ghÿ`ea,,ÿ`'
`cbkkbl'w
`ÿ
`AMJ77B7CE
`ÿ=?ÿÿÿÿÿÿÿxyz{|}ÿyÿz }
`ÿ`.T,j0Nb\ÿs.#ÿbcÿTOU TVPOWX 53QYÿOYW P Q5ÿN'ÿ/,a,ghÿ`1,\],]ÿ`\]ÿa,'0`0,]ÿN\ÿN0'ÿ,\0Na,0hÿ`'ÿcbkkbl'w
`ÿ[ 0b\ÿ'/`kkÿa,j,Nr,ÿ#&&ÿbcÿ0/,ÿcNa'0ÿ&&f&&&ÿbcÿkNc,0N1,ÿiab]dj0ÿiabcN0ÿ`'ÿjb1m,\'`0Nb\ÿcbaÿ`]]N0Nb\`k
`1`\dc`j0daN\eÿjb'0'ÿN\jdaa,]oÿ0/,a,`c0,aÿOUÿ'/`kkÿa,j,Nr,ÿ#&&ÿbcÿ0/,ÿ\,-0ÿ#f&&&f&&&ÿbcÿkNc,0N1,ÿiab]dj0
`iabcN0'oÿ0/,a,`c0,afÿOUÿ'/`kkÿa,j,Nr,ÿ)ÿbcÿ`kkÿiab]dj0ÿiabcN0fÿTnTÿ'/`kkÿa,j,Nr,ÿ#).ÿbcÿ`kkÿiab]dj0ÿiabcN0'f
``\]ÿRniÿ'/`kkÿa,j,Nr,ÿ#).ÿbcÿ`kkÿiab]dj0ÿiabcN0ÿZjbkk,j0Nr,khÿ0/,ÿ[iabcN0ÿT/`a,'^_fÿ`\]ÿ 0b\ÿ'/`kkÿa,0`N\ÿ0/,
`a,1`N\N\eÿ&ÿbcÿ0/,ÿiab]dj0ÿiabcN0.^
`ÿ
`ÿÿÿÿÿ
`ÿÿ
`
`
`
`
`
`
`
`
`EXELA 2013
`Eton Pharmaceuticals v. Exela Pharma Sciences
`PGR2020-00068
`
`
`
`https://www.sec.gov/Archives/edgar/data/1710340/000161577418011027/s113298_ex10-18.htm
`
`IN WITNESS WHEREOF,the parties hereto have executed this Amendmentasofthe date first above written.
`
`Eton Pharmaceuticals, Inc.
`
`/s/ Sean Brynjelsen
`By:
`Name: Sean Brynjelsen
`Title: CEO
`
`AL Pharma,Inc.
`
`/s/ Warren Johnson
`By:
`Name: Warren Johnson
`Title: Vice President
`
`
`
`
`
`"#ÿ$"%#&''ÿ$(&)&*+,ÿ-./ÿ012-3/4ÿ./2/-5ÿ.16/ÿ/7/89-/:ÿ-.34ÿ;</=:</=-ÿ14ÿ5>ÿ-./ÿ:1-/ÿ>324-ÿ1?56/ÿ@23--/=A
`&-5=ÿB.12<18/9-381C4,ÿ"=8A
`ÿ
`ÿ
`DEFG4Gÿ'/1=ÿD2E=H/C4/=
`#1</Fÿÿ'/1=ÿD2E=H/C4/=
`%3-C/FI&*
`ÿ
`ÿ
`;JÿB.12<1,ÿ"=8A
`ÿ
`ÿ
`DEFG4Gÿ$122/=ÿK5.=45=
`#1</F$122/=ÿK5.=45=
`%3-C/FL38/ÿB2/43:/=-
`ÿ
`ÿ
`'I'ÿ#1-35=1C,ÿJJI
`ÿ
`ÿ
`DEFG4Gÿ'-1=C/Eÿ$AÿI9==3=M.1<
`#1</F'-1=C/Eÿ$AÿI9==3=M.1<
`%3-C/FB2/43:/=-
`ÿ
`ÿ
`N2EÿI2//OÿB25H/8-,ÿJJI
`ÿ
`ÿ
`DEFG4GÿK5.=ÿ(5>4-/--/2,ÿNAB.A
`#1</FK5.=ÿ(5>4-/--/2,ÿNAB.A
`%3-C/FB2/43:/=-
`
`SCS National, LLC
`
`/s/ Stanley W. Cunningham
`By:
`Name: Stanley W. Cunningham
`Title:
`President
`
`Dry Creek Project, LLC
`
`/s/ John Hofstetter, D.Ph.
`By:
`Name: John Hofstetter, D.Ph.
`Title:
`President
`
`ÿ
`
`2/7/2020
`
`
`ÿÿ
`ÿÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿ
`ÿÿÿ
`
`https://www.sec.gov/Archives/edgar/data/1710340/000161577418011027/s113298_ex10-18.htm
`
`
`
`
`
`
`
`
`